Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism GlyT1 inhibitors(Glycine transporter 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC3H7NO2 |
InChIKeyFSYKKLYZXJSNPZ-UHFFFAOYSA-N |
CAS Registry107-97-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Depressive Disorder, Major | Phase 2 | Taiwan Province | 01 Apr 2009 | |
Schizophrenia | Phase 2 | Taiwan Province | 01 Mar 2009 | |
Chronic schizophrenia | Phase 2 | Taiwan Province | 01 Jan 2005 | |
Depressive Disorder | Phase 2 | - | - | |
Depressive Disorder | Phase 2 | - | - | |
Obsessive-Compulsive Disorder | Phase 2 | - | - | |
Obsessive-Compulsive Disorder | Phase 2 | - | - |
Not Applicable | 92 | (Malignant tissue) | eekqjjadrf(kjsehpqdnk) = vkgfapyfux rovxwgrapg (gkrgjafyse ) | Negative | 01 Apr 2011 |